Cargando…
Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
The present study compared the efficacy of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) in the estimation of hepatic fibrosis stages with histopathologic correlation. This retrospective s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662416/ https://www.ncbi.nlm.nih.gov/pubmed/29049250 http://dx.doi.org/10.1097/MD.0000000000008339 |
_version_ | 1783274640070672384 |
---|---|
author | Wu, Wen-Pei Hoi, Cheng-In Chen, Ran-Chou Lin, Ching-Po Chou, Chen-Te |
author_facet | Wu, Wen-Pei Hoi, Cheng-In Chen, Ran-Chou Lin, Ching-Po Chou, Chen-Te |
author_sort | Wu, Wen-Pei |
collection | PubMed |
description | The present study compared the efficacy of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) in the estimation of hepatic fibrosis stages with histopathologic correlation. This retrospective study included 104 patients (87 men and 17 women; mean age, 60.6 ± 10.6 years) with chronic liver disease who underwent both Gd-EOB-DTPA-enhanced MRI and MRE. The relative enhancement (RE) ratio of the liver parenchyma and the contrast enhancement index (CEI) were calculated as (SI(postliver) − SI(preliver))/SI(preliver) and SI(post)/SI(pre), respectively, where SI(post) and SI(pre) were the liver-to-muscle signal intensity ratios on the hepatobiliary phase images and noncontrast-enhanced images, respectively. The liver stiffness values were measured using MRE stiffness maps. The diagnostic performance of MRE, RE ratios, and CEI values for hepatic fibrosis staging were compared. The distribution of fibrosis stages was as follows: F0, n = 3 (2.9%); F1, n = 12 (11.5%); F2, n = 17 (16.3%); F3, n = 26 (25.0%); and F4, n = 46 (44.2%). MRE, RE ratios, and CEI values correlated significantly with hepatic fibrosis (r(s) = .79, −.35, −.25, respectively, P < .05). MRE showed a significantly higher diagnostic performance than did RE ratios and CEI values for each fibrosis stage, except while distinguishing the F1 fibrosis stage (CEI, P = .15). A cutoff value of RE ratio = 0.89 can be used to identify patients with significant hepatic fibrosis, with positive predictive value, sensitivity, specificity, and negative predictive value of 93.2%, 61.8%, 73.3%, and 24.4%, respectively. Gd-EOB-DTPA-enhanced MRI can potentially predict significant hepatic fibrosis. However, the diagnostic performance of MRE for hepatic fibrosis staging was superior to that of Gd-EOB-DTPA-enhanced MRI. |
format | Online Article Text |
id | pubmed-5662416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-56624162017-11-21 Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis Wu, Wen-Pei Hoi, Cheng-In Chen, Ran-Chou Lin, Ching-Po Chou, Chen-Te Medicine (Baltimore) 6800 The present study compared the efficacy of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) in the estimation of hepatic fibrosis stages with histopathologic correlation. This retrospective study included 104 patients (87 men and 17 women; mean age, 60.6 ± 10.6 years) with chronic liver disease who underwent both Gd-EOB-DTPA-enhanced MRI and MRE. The relative enhancement (RE) ratio of the liver parenchyma and the contrast enhancement index (CEI) were calculated as (SI(postliver) − SI(preliver))/SI(preliver) and SI(post)/SI(pre), respectively, where SI(post) and SI(pre) were the liver-to-muscle signal intensity ratios on the hepatobiliary phase images and noncontrast-enhanced images, respectively. The liver stiffness values were measured using MRE stiffness maps. The diagnostic performance of MRE, RE ratios, and CEI values for hepatic fibrosis staging were compared. The distribution of fibrosis stages was as follows: F0, n = 3 (2.9%); F1, n = 12 (11.5%); F2, n = 17 (16.3%); F3, n = 26 (25.0%); and F4, n = 46 (44.2%). MRE, RE ratios, and CEI values correlated significantly with hepatic fibrosis (r(s) = .79, −.35, −.25, respectively, P < .05). MRE showed a significantly higher diagnostic performance than did RE ratios and CEI values for each fibrosis stage, except while distinguishing the F1 fibrosis stage (CEI, P = .15). A cutoff value of RE ratio = 0.89 can be used to identify patients with significant hepatic fibrosis, with positive predictive value, sensitivity, specificity, and negative predictive value of 93.2%, 61.8%, 73.3%, and 24.4%, respectively. Gd-EOB-DTPA-enhanced MRI can potentially predict significant hepatic fibrosis. However, the diagnostic performance of MRE for hepatic fibrosis staging was superior to that of Gd-EOB-DTPA-enhanced MRI. Wolters Kluwer Health 2017-10-20 /pmc/articles/PMC5662416/ /pubmed/29049250 http://dx.doi.org/10.1097/MD.0000000000008339 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 6800 Wu, Wen-Pei Hoi, Cheng-In Chen, Ran-Chou Lin, Ching-Po Chou, Chen-Te Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
title | Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
title_full | Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
title_fullStr | Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
title_full_unstemmed | Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
title_short | Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
title_sort | comparison of the efficacy of gd-eob-dtpa-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis |
topic | 6800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662416/ https://www.ncbi.nlm.nih.gov/pubmed/29049250 http://dx.doi.org/10.1097/MD.0000000000008339 |
work_keys_str_mv | AT wuwenpei comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis AT hoichengin comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis AT chenranchou comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis AT linchingpo comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis AT chouchente comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis |